Health Canada holding off on Johnson & Johnson COVID-19 vaccine distribution


Newly arrived doses processed in U.S. plant mired in quality-control problems Health Canada is holding off on distributing the first shipment of Johnson & Johnson’s COVID-19 vaccine after it became clear the doses that arrived on Wednesday were processed in the same U.S. plant that’s been mired in quality-control problems. Reports first surfaced in the New York Times earlier this month about problems at a Baltimore, Md., plant run by Emergent BioSolutions, where both the AstraZeneca-Oxford and Johnson & Johnson vaccines were being manufactured. Emergent announced earlier this month that 15 million doses of the latter had been ruined by cross-contamination — a development that prompted the White House to put Johnson & Johnson in charge of the facility. Canada received 300,000 doses this week, Health Canada told CBC News.

Notifications - Subscriptions
Notify of
Oldest Most Voted
Inline Feedbacks
View all comments

Would love your thoughts, please comment.x